ClinicalTrials.Veeva

Menu

Diurnal Evaluation of OSA Upper Airway Collapsibility and Muscle Responsiveness (Muscle-OSA)

I

Istituto Auxologico Italiano

Status

Enrolling

Conditions

Obstructive Sleep Apnea

Treatments

Diagnostic Test: Tests of upper airway collapsibility and muscle responsiveness.

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

In the framework of pathophysiological trait in obstructive sleep apnea (OSA) patients, a simplified method is proposed to measure upper airway (UA) collapsibility and muscle responsiveness during wakefulness.

Enrollment

66 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Obstructive Sleep Apnea (OSA)
  • At home-polygraphy with at least one EEG channel (PSG) reporting moderate-to severe obstructive sleep apnea (apnea-hypopnea index >14).

Exclusion criteria

  • OSA treatment ongoing during two weeks before PSG
  • Unstable cardio-respiratory disease in the 3 months before enrollment
  • Subjects in O2 treatment

Trial design

66 participants in 1 patient group

Obstructive Sleep Apnea
Description:
Patients evaluated for sleep disorders, who present an at home-polygraphy with at least one EEG channel (PSG) reporting moderate-to severe obstructive sleep apnea (apnea-hypopnea index \>14).
Treatment:
Diagnostic Test: Tests of upper airway collapsibility and muscle responsiveness.

Trial contacts and locations

1

Loading...

Central trial contact

Elisa Perger, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems